Latest news
{{'Tue, 11 Aug 2026 08:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk's Awiqli®, the first once-weekly basal insulin for adults with type 2 diabetes, now available in the US
Read more
{{'Tue, 04 Aug 2026 16:12:00 -0400' | dateFormatUsFilter}}
Financial report for the period January 1, 2026 to June 30, 2026
Read more
{{'Tue, 21 Jul 2026 07:35:00 -0400' | dateFormatUsFilter}}
Novo Nordisk Takes Action to Stop Multiple Misleading National GLP-1 Advertising Campaigns by Eli Lilly
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.